Glycogen synthase kinase (GSK) 3 in pregnancy and parturition: a systematic review of literature.
Human reproduction is a multifaceted process reliant on proper blastocyst implantation, placental and fetal membrane development, and delivery of a healthy baby. Multiple factors and pathways have been reported as critical machineries for cell differentiation and survival during pregnancy, and most of them involve glycogen synthase kinase (GSK) 3α/β for cell differentiation and survival and for maintaining cellular homeostasis. Several reports on GSK3's functional role exist; however, the specific role of GSK3 in reproductive tissues and its contribution to normal or abnormal parturition are still unclear. To fill this knowledge gap, a systematic review of literature was conducted to better understand the functional role of GSK3 in various intrauterine tissues during implantation, pregnancy, and parturition. We conducted a systematic review of English literature published between 1980 and 2017 on GSK3's expression and function reported in reproductive tissues during pregnancy using 3 electronic databases (Web of Science, Medline, and ClinicalTrials.gov). Study selection, data extraction, and quality assessment were performed in duplicate by two independent reviewers. A total of 738 citations were identified; 80 were selected for full text evaluation and 25 were included for final review. GSK3's regulation and function were mostly studied in tissues and cells from placentas (12), fetuses (8), uteruses (6), and ovaries (2). Measurements of total GSK3 and its isoforms (α and/or β) were determined mostly by Western blot analysis. GSK3 is primarily reported as a downstream responder of protein kinase B (AKT)-, Wnt-, and reactive oxygen species (ROS)-related pathways where it plays a critical role in cell survival and growth in reproductive tissues. GSK3 is functionally linked to blastocyst implantation, establishment of pregnancy, trophoblast migration and invasion, decidualization, and term and preterm labor. Few reports specifically studied GSK3's expression and function in any reproductive tissues; it has mostly been studied as a secondary signaler of various conserved cell signaling pathways. Lack of scientific rigor in studying GSK3's role in reproductive tissues makes this molecule's function still obscure. No studies have reported GSK3 in the cervix, and very few reports exist in myometrium and decidua. GSK3's functions are hardly studied in reproductive tissues, and several knowledge gaps have been identified that require more functional studies in reproductive biology.